Showing all 7 results Retatrutide is an investigational GLP-1, GIP, and glucagon receptor triple agonist developed by Eli Lilly, representing the broadest mechanistic profile among current weight loss and metabolic peptides in clinical development
MOTS-C + Retatrutide Supply Options These product links match the two peptides discussed in this option
Virus-Induced Tubules: A vehicle for spread of virions into ovary oocyte cells of an insect vector
If you notice stool colour changes whilst taking GLP-1 medication, consider recent dietary intake and any new medications or supplements before attributing the change to your GLP-1 therapy
A higher percentage of the active compound reaching systemic circulation, and often, a faster onset of action
Today, we'll dive into what semaglutide is, how it works, its benefits, and even some fun facts